Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check18 days agoChange DetectedThe page has been updated to include new study details for the RP1 Monotherapy and its combination with Nivolumab, along with the latest revision number and a disclaimer about government review. The previous revision number has been removed.SummaryDifference24%
- Check25 days agoChange DetectedThe web page has undergone a revision update from v2.16.1 to v2.16.2, and several key details related to a specific study have been removed, including the study title, clinical trial ID, and sponsor information.SummaryDifference19%
- Check33 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check40 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.